Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred I Lee

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infectionLina Ma, Sanjaya K Sahu, Marlene Cano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Nature Medicine|June 19, 2021
Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19Carolina Lucas, Jon Klein, Maria E Sundaram, et al.
Nature Medicine|May 6, 2021
Delayed production of neutralizing antibodies correlates with fatal COVID-19Carolina Lucas, Jon Klein, Maria E Sundaram, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infectionLina Ma, Sanjaya K Sahu, Marlene Cano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Nature Medicine|June 19, 2021
Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19Carolina Lucas, Jon Klein, Maria E Sundaram, et al.
Nature Medicine|May 6, 2021
Delayed production of neutralizing antibodies correlates with fatal COVID-19Carolina Lucas, Jon Klein, Maria E Sundaram, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Pageof 7